PrecisePK Redefines Precision Dosing with Academic Integration, Setting New Standards In Therapeutic Drug Monitoring
Today, PrecisePK announces its significant strides in transforming healthcare in South America through integration into key healthcare and educational institutions. The esteemed Bayesian Model-Informed Precision Dosing (MIPD) software continues its ascendancy, earning recognition from the esteemed Chilean educational institution, Escuela de Química y…
K36 Therapeutics Announces Appointment of Benjamin Winograd, MD, PhD, as Chief Medical Officer
K36 Therapeutics, Inc. (“K36”), a clinical-stage biotech company focused on developing its first-in-class MMSET inhibitor KTX-1001 for t(4;14) multiple myeloma, today announced that Benjamin Winograd, MD, PhD, has been appointed Chief Medical Officer to lead the Medical and Clinical teams. Dr. Winograd joins…
Allelica launches the Allelica Precision Server, an on-premises solution for clinical bioinformatics analyses
Allelica, the leading provider of software tools for clinical bioinformatics, announced the launch of its latest innovation, the Allelica Precision Server (APS). APS revolutionizes the way medical laboratories approach clinical bioinformatics analyses, streamlining polygenic risk score (PRS), pharmacogenomics (PGx), and…
Oncoclínicas opens first Cancer Center in Brazil as an International Collaborative Member of Dana-Farber Cancer Institute
Oncoclínicas&Co, the largest group dedicated to cancer in Latin America, and Dana-Farber Cancer Institute, a Harvard Medical School affiliated teaching hospital and one of the world’s leading cancer treatment and oncology research institutions, announce the expansion of their collaboration with the opening of…
Oregon Health & Science University (OHSU) to utilize RayStation technology for radiation therapy planning
RaySearch Laboratories AB (publ) announces that Oregon Health & Science University (OHSU) in the USA has placed an order for the treatment planning system RayStation®*. OHSU has purchased RayStation for treatment planning which will be used with the Radixact system from Accuray….
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
According to the American Cancer Society in its Cancer Facts & Figures 2023 report, the five-year survival rate for pancreatic cancer increased by 1% from the previous year to 12%. The increase has generated more optimism from the Pancreatic Cancer Action Network (PanCAN), whose President and CEO Julie…
EntroGen Receives FDA Approval for CRCdx® RAS Mutation Detection Kit as Companion Diagnostic for Vectibix®
The U.S. Food and Drug Administration (FDA) has granted approval for EntroGen’s CRCdx® RAS Mutation Detection Kit as a companion diagnostic for Vectibix® (panitumumab), a targeted therapy used in the treatment of colorectal cancer. This landmark premarket approval (PMA) marks…
Henlius’ Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC
Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new indication of HANSIZHUANG (serplulimab injection), an innovative anti-PD-1 monoclonal antibody independently developed by the company, in combination with drugs containing fluorouracil and platinum for the…
MGI Partners with Gencell to Expand Genomics in Latin America
MGI, a company committed to building core tools and technology to lead life science, is thrilled to announce a strategic partnership with Gencell, a health company focused on molecular biology and genetic services in Colombia and the broader LATAM region….
National University Health System Launches World’s First Public Hospital’s Healthy Longevity Clinic at Alexandra Hospital
The National University Health System (NUHS), NUS Yong Loo Lin School of Medicine and Alexandra Hospital (AH) have achieved a milestone by unveiling the world’s inaugural Healthy Longevity Clinic by public healthcare. Located at Singapore’s Alexandra Hospital, the clinic aims…
